Other GI side effects, like nausea, diarrhea, and vomiting, were also more frequent but were usually mild to moderate
On December 22, 2025, the FDA approved oral Wegovy (semaglutide 25mg tablet) the first and only oral GLP-1 medication for chronic weight management
Ideally, keep it as close to your regular seven-day interval as possible
Our Score: 9.7/10 | Trustpilot: 4.8 across 350,000 patients (on-site claim) Overview Embody is a relatively new GLP-1 telehealth provider that built its reputation on flat pricing that doesnt change as your dose goes up
The responsibility for ensuring the quality and safety of the medication lies in the hands of the compounding pharmacist
Research shows that most patients on semaglutide pay through commercial insurance